New app aims to ease amputation dilemmas for diabetic foot patients
NCT ID NCT07252089
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an electronic decision-support tool can help diabetic foot patients feel less conflicted about amputation decisions. 80 patients with severe foot ulcers or infections will use the tool via a WeChat Mini Program, alongside standard care. Researchers will measure changes in decisional conflict and satisfaction with choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
electronic decision-support tool delivered via WeChat Mini Program
What this could lead to
If it works, this could give diabetic foot patients a clearer way to make tough amputation decisions, reducing stress and regret.
What could go wrong
This is a small, early-stage study with only 80 participants, so results may not apply to everyone. The tool is new and its real-world impact is unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT DISEASE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.